TRANCE/RANK L/TNFSF11/CD254
-
Catalog numberE21-K63
-
PricePlease ask
-
Size10ug
-
-
Shipping_TemperatureAmbient
-
Product_StateLyophilized
-
Formulation_DescriptionLyophilized from a 0.2 μm filtered solution of 20mM Tris,150mM NaCl,pH8.0.
-
StorageLyophilized protein should be stored at < -20°C, though stable at room temperature for 3 weeks.Reconstituted protein solution can be stored at 4-7°C for 2-7 days.Aliquots of reconstituted samples are stable at < -20°C for 3 months.
-
ReconstitutionAlways centrifuge tubes before opening. Do not mix by vortex or pipetting.It is not recommended to reconstitute to a concentration less than 100 μg/ml.Dissolve the lyophilized protein in ddH2O.Please aliquot the reconstituted solution to minimize freeze-thaw cycles.
-
PurityGreater than 95% as determined by reducing SDS-PAGE.
-
EndotoxinLess than 0.1 ng/µg (1 IEU/µg) as determined by LAL test.
-
BackgroundCD254, also known as RANKL, TNFSF11, TRANCE, OPGL and ODF, is a type II membrane protein of the tumor necrosis factor (TNF) superfamily, and affects the immune system and control bone regeneration and remodeling. RANKL is the ligand of nuclear factor (NF)-κB (RANK). When RANKL binds to RANK, it will undergo trimerization and then bind to an adaptor molecule TNF receptor-associated factor 6 (TRAF6). This results in the activation of several downstream signaling cascades, including the NFκB, mitogen-activated protein kinases (MAPK), activating protein 1 (AP-1), and nuclear factor of activated T cells (NFATc1), resulting in the formation of multinucleated bone-resorbing osteoclasts. RANKL is widely expressed in skeletal muscle, thymus, liver, colon, small intestine, adrenal gland, osteoblast, mammary gland epithelial cells, prostate and pancreas.
-
Alternative NamesCD254; ODF; OPGL; RANK L; TNFSF11; CD254; Osteoclast differentiation factor; Receptor activator of nuclear factor kappa-B ligand; tumor necrosis factor ligand superfamily member 11
-
Expression systemE.coli
-
Gene target
-
Gene symbolTNFSF11, TNFRSF11A, ANKFY1
-
Short nameTRANCE/RANK L/TNFSF11/CD254
-
SpeciesHuman
-
Alternative nameTRANCE/RANK L/tumor necrosis factor (ligand) superfamily, member 11/CD254
-
Alternative to gene targettumor necrosis factor (ligand) superfamily, member 11, CD254 and hRANKL2 and ODF and OPGL and OPTB2 and RANKL and sOdf and TRANCE, TNFSF11 and IDBG-28393 and ENSG00000120659 and 8600, tumor necrosis factor receptor superfamily binding, Extracellular, Tnfsf11 and IDBG-182101 and ENSMUSG00000022015 and 21943, TNFSF11 and IDBG-628731 and ENSBTAG00000008924 and 513836
-
Gene info
-
Identity
-
Gene
-
Long gene nameTNF superfamily member 11
-
Synonyms gene name
- tumor necrosis factor (ligand) superfamily, member 11
-
Synonyms
-
GenBank acession
-
Locus
-
Discovery year1998-12-04
-
Pubmed identfication
-
Classification
- Tumor necrosis factor superfamily
- CD molecules
-
VEGA ID
Gene info
-
Identity
-
Gene
-
Long gene nameTNF receptor superfamily member 11a
-
Synonyms gene
-
Synonyms gene name
- tumor necrosis factor receptor superfamily, member 11a, activator of NFKB
- Paget disease of bone 2
- loss of heterozygosity, 18, chromosomal region 1
- tumor necrosis factor receptor superfamily, member 11a, NFKB activator
-
Synonyms
-
Synonyms name
-
GenBank acession
-
Locus
-
Discovery year1998-12-04
-
Entrez gene record
-
Pubmed identfication
-
Classification
- CD molecules
- Tumor necrosis factor receptor superfamily
-
VEGA ID
-
Locus Specific Databases
Gene info
-
Identity
-
Gene
-
Long gene nameankyrin repeat and FYVE domain containing 1
-
Synonyms
-
Synonyms name
-
GenBank acession
-
Locus
-
Discovery year2003-04-29
-
Entrez gene record
-
Pubmed identfication
-
RefSeq identity
-
Classification
- Zinc fingers FYVE-type
- BTB domain containing
- Ankyrin repeat domain containing
-
VEGA ID